Cochlear Limited (ASX:COH)
298.53
-0.25 (-0.08%)
Sep 5, 2025, 4:10 PM AEST
Cochlear Company Description
Cochlear Limited provides implantable hearing solutions for children and adults worldwide.
The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products.
It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories.
The company was founded in 1981 and is headquartered in Sydney, Australia.
Cochlear Limited

Country | Australia |
Founded | 1981 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 5,500 |
CEO | Diggory Howitt |
Contact Details
Address: 1 University Avenue Sydney, NSW 2109 Australia | |
Phone | 61 2 9428 6555 |
Website | cochlear.com |
Stock Details
Ticker Symbol | COH |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000COH5 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Diggory William Howitt BE (Hons), MBA | Chief Executive Officer, MD, President and Executive Director |
Dr. Sarah Thom | Chief Financial Officer |
Jan Janssen MSc Elec Eng | Chief Technology Officer |
Stuart Sayers | President of Asia Pacific and Latin America |
Karen O'Driscoll | Chief Information Officer |
Kristina Devon | Vice President of Investor Relations |
Rob McGrory | Group General Counsel and Company Secretary |
Jennifer Stevenson | Vice President of Corporate Communications and Brand |
Dean Phizacklea | Senior Vice President of Global Strategic Marketing |
Jennifer Hornery | Senior Vice President of Global People and Culture |